Trial Profile
Effect of food and age on the pharmacokinetics of NEPA (a fixed-dose combination of netupitant and palonosetron) in healthy volunteers
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 24 Oct 2015
Price :
$35
*
At a glance
- Drugs Netupitant/palonosetron (Primary)
- Indications Chemotherapy-induced nausea and vomiting
- Focus Adverse reactions; Pharmacokinetics
- Sponsors Helsinn
- 01 Sep 2015 Results of subgroup analysis (n=12) published in the Clinical Pharmacology in Drug Development
- 20 Mar 2014 New trial record